Authors: | Kantor, E.; Bhimani, J.; Gallagher, G. B.; Blinder, V. S.; Burganowski, R. P.; Griggs, J. J.; Kolevska, T.; Kroenke, C.; Laurent, C.; Liu, R.; Nakata, K. G.; O'Connell, K.; Persaud, S.; Rivera, D.; Roh, J. M.; Valice, E.; Wang, P.; Bandera, E. V.; Bowles, E. A.; Kushi, L. H. |
Abstract Title: | Patient factors associated with chemotherapy modifications: Results from the Optimal Breast Cancer Chemotherapy Dosing (OBCD) study |
Meeting Title: | 2024 ASCO Annual Meeting |
Journal Title: | Journal of Clinical Oncology |
Volume: | 42 |
Issue: | 16 Suppl. |
Meeting Dates: | 2024 May 31-Jun 4 |
Meeting Location: | Chicago, IL |
ISSN: | 0732-183X |
Publisher: | American Society of Clinical Oncology |
Date Published: | 2024-06-01 |
Language: | English |
ACCESSION: | WOS:001275557400023 |
PROVIDER: | wos |
DOI: | 10.1200/JCO.2024.42.16_suppl.520 |
Notes: | Meeting Abstract: 520 -- Source: Wos |